{"id":29937,"date":"2023-11-13T10:39:54","date_gmt":"2023-11-13T13:39:54","guid":{"rendered":"https:\/\/www.federassantas.org.br\/novosite\/?p=29937"},"modified":"2023-11-13T10:42:50","modified_gmt":"2023-11-13T13:42:50","slug":"sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura","status":"publish","type":"post","link":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/","title":{"rendered":"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"29937\" class=\"elementor elementor-29937\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-61b0417 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"61b0417\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7c74b16\" data-id=\"7c74b16\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-25f98b1 elementor-widget elementor-widget-heading\" data-id=\"25f98b1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5d42417 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5d42417\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7607e39\" data-id=\"7607e39\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-57345fd elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"57345fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>M<i>edicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C<\/i>.<\/p><p>O tratamento da hepatite C no Sistema \u00danico de Sa\u00fade (SUS) ganhar\u00e1 uma nova op\u00e7\u00e3o com alto percentual de cura a partir de novas entregas realizadas pelo Instituto de Tecnologia em F\u00e1rmacos da Funda\u00e7\u00e3o Oswaldo Cruz (Farmanguinhos\/Fiocruz). A Fiocruz divulgou\u00a0 que o laborat\u00f3rio p\u00fablico entregou 800,8 mil unidades farmac\u00eauticas dos medicamentos sofosbuvir e daclatasvir ao Minist\u00e9rio da Sa\u00fade.<\/p><p>Essa \u00e9 a primeira vez que Farmanguinhos disponibiliza esses medicamentos ao SUS, o que se deu por meio de uma parceria de transfer\u00eancia de tecnologia com a farmac\u00eautica Blanver S.A.<\/p><p class=\"texto\">Segundo a Fiocruz, a combina\u00e7\u00e3o sofosbuvir e daclatasvir produzida por seu instituto representar\u00e1 uma economia de cerca de R$ 40 milh\u00f5es ao ano ao Sistema \u00danico de Sa\u00fade (SUS) para o tratamento da hepatite C.<\/p><p class=\"texto\">Farmanguinhos j\u00e1 produz o medicamento ribavirina para o tratamento de hepatites virais e agora ser\u00e1 o primeiro laborat\u00f3rio p\u00fablico no pa\u00eds a produzir medicamentos associados ao sofosbuvir, que \u00e9 efetivo contra diferentes tipos de v\u00edrus causadores da hepatite.<\/p><p class=\"texto\">Al\u00e9m disso, o instituto estabeleceu recentemente um acordo para fornecer o ravidasvir, que tamb\u00e9m trata a hepatite C, em parceria com a DNDi e a farmac\u00eautica eg\u00edpcia Pharco Pharmaceuticals.<\/p><p class=\"texto\">Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C.<\/p><p class=\"texto\">Entre 2000 e 2021, o Brasil confirmou 718.651 casos de hepatites virais, segundo o Minist\u00e9rio da Sa\u00fade. O Boletim Epidemiol\u00f3gico das Hepatites Virais detalha que 168.175 (23,4%) foram de hepatite A, 264.640 (36,8%) de hepatite B, 279.872 (38,9%) de hepatite C e 4.259 (0,6%) de hepatite D.<\/p><p class=\"texto\">Fonte: Estado de Minas<\/p><p>Link: <a href=\"https:\/\/www.em.com.br\/saude\/2023\/11\/6652679-sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura.htm\">https:\/\/www.em.com.br\/saude\/2023\/11\/6652679-sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura.htm<\/a>l<\/p><p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C. Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C. O tratamento da hepatite C no Sistema \u00danico de Sa\u00fade (SUS) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":29938,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[143],"tags":[467,469,504],"class_list":["post-29937","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-publicas","tag-clipagem","tag-estado-de-minas","tag-hepatite-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura - Federassantas<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura - Federassantas\" \/>\n<meta property=\"og:description\" content=\"Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C. Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C. O tratamento da hepatite C no Sistema \u00danico de Sa\u00fade (SUS) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\" \/>\n<meta property=\"og:site_name\" content=\"Federassantas\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-13T13:39:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-13T13:42:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1170\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin-federas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin-federas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\"},\"author\":{\"name\":\"admin-federas\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/person\/75fed98158349313fe56175f232f513c\"},\"headline\":\"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura\",\"datePublished\":\"2023-11-13T13:39:54+00:00\",\"dateModified\":\"2023-11-13T13:42:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\"},\"wordCount\":352,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp\",\"keywords\":[\"Clipagem\",\"Estado de Minas\",\"Hepatite C\"],\"articleSection\":[\"Not\u00edcias P\u00fablicas\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\",\"url\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\",\"name\":\"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura - Federassantas\",\"isPartOf\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp\",\"datePublished\":\"2023-11-13T13:39:54+00:00\",\"dateModified\":\"2023-11-13T13:42:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage\",\"url\":\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp\",\"contentUrl\":\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp\",\"width\":1170,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/www.federassantas.org.br\/novosite\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#website\",\"url\":\"https:\/\/www.federassantas.org.br\/novosite\/\",\"name\":\"Federassantas\",\"description\":\"Fed. das Santas Casas e Hospitais Filantr\u00f3picos de MG\",\"publisher\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.federassantas.org.br\/novosite\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#organization\",\"name\":\"Federassantas\",\"url\":\"https:\/\/www.federassantas.org.br\/novosite\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2021\/12\/logo.png\",\"contentUrl\":\"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2021\/12\/logo.png\",\"width\":243,\"height\":59,\"caption\":\"Federassantas\"},\"image\":{\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/person\/75fed98158349313fe56175f232f513c\",\"name\":\"admin-federas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2a02d7dda59fe8dc6b7ffd3f652e2efede5ccf0dd89dfdc8137c5517f3de8407?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2a02d7dda59fe8dc6b7ffd3f652e2efede5ccf0dd89dfdc8137c5517f3de8407?s=96&d=mm&r=g\",\"caption\":\"admin-federas\"},\"sameAs\":[\"https:\/\/www.federassantas.org.br\/novosite\/\"],\"url\":\"https:\/\/www.federassantas.org.br\/novosite\/author\/admin-federas\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura - Federassantas","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/","og_locale":"pt_BR","og_type":"article","og_title":"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura - Federassantas","og_description":"Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C. Medicamentos como o sofosbuvir e daclatasvir s\u00e3o as recomenda\u00e7\u00f5es preferenciais da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) para o tratamento da hepatite C. O tratamento da hepatite C no Sistema \u00danico de Sa\u00fade (SUS) [&hellip;]","og_url":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/","og_site_name":"Federassantas","article_published_time":"2023-11-13T13:39:54+00:00","article_modified_time":"2023-11-13T13:42:50+00:00","og_image":[{"width":1170,"height":700,"url":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp","type":"image\/webp"}],"author":"admin-federas","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin-federas","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#article","isPartOf":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/"},"author":{"name":"admin-federas","@id":"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/person\/75fed98158349313fe56175f232f513c"},"headline":"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura","datePublished":"2023-11-13T13:39:54+00:00","dateModified":"2023-11-13T13:42:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/"},"wordCount":352,"commentCount":0,"publisher":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/#organization"},"image":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage"},"thumbnailUrl":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp","keywords":["Clipagem","Estado de Minas","Hepatite C"],"articleSection":["Not\u00edcias P\u00fablicas"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/","url":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/","name":"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura - Federassantas","isPartOf":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage"},"image":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage"},"thumbnailUrl":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp","datePublished":"2023-11-13T13:39:54+00:00","dateModified":"2023-11-13T13:42:50+00:00","breadcrumb":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#primaryimage","url":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp","contentUrl":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2023\/11\/1_hepatite-32036750.webp","width":1170,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.federassantas.org.br\/novosite\/sus-novo-remedio-para-hepatite-c-tem-alto-percentual-de-cura\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.federassantas.org.br\/novosite\/"},{"@type":"ListItem","position":2,"name":"SUS: novo rem\u00e9dio para hepatite C tem alto percentual de cura"}]},{"@type":"WebSite","@id":"https:\/\/www.federassantas.org.br\/novosite\/#website","url":"https:\/\/www.federassantas.org.br\/novosite\/","name":"Federassantas","description":"Fed. das Santas Casas e Hospitais Filantr\u00f3picos de MG","publisher":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.federassantas.org.br\/novosite\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.federassantas.org.br\/novosite\/#organization","name":"Federassantas","url":"https:\/\/www.federassantas.org.br\/novosite\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/logo\/image\/","url":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2021\/12\/logo.png","contentUrl":"https:\/\/www.federassantas.org.br\/novosite\/wp-content\/uploads\/2021\/12\/logo.png","width":243,"height":59,"caption":"Federassantas"},"image":{"@id":"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/person\/75fed98158349313fe56175f232f513c","name":"admin-federas","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.federassantas.org.br\/novosite\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2a02d7dda59fe8dc6b7ffd3f652e2efede5ccf0dd89dfdc8137c5517f3de8407?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a02d7dda59fe8dc6b7ffd3f652e2efede5ccf0dd89dfdc8137c5517f3de8407?s=96&d=mm&r=g","caption":"admin-federas"},"sameAs":["https:\/\/www.federassantas.org.br\/novosite\/"],"url":"https:\/\/www.federassantas.org.br\/novosite\/author\/admin-federas\/"}]}},"_links":{"self":[{"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/posts\/29937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/comments?post=29937"}],"version-history":[{"count":4,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/posts\/29937\/revisions"}],"predecessor-version":[{"id":29942,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/posts\/29937\/revisions\/29942"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/media\/29938"}],"wp:attachment":[{"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/media?parent=29937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/categories?post=29937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.federassantas.org.br\/novosite\/wp-json\/wp\/v2\/tags?post=29937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}